• Home Marcos de Lima.

Marcos de Lima.

McMannis, Ph.D., Indreshpal Kaur, Ph.D., Partow Kebriaei, M.D., Simrit Parmar, M.D., Uday Popat, M.D., Chitra Hosing, M.D., Richard Champlin, M.D., Catherine Bollard, M.D., Jeffrey J. Molldrem, M.D., Roy B. Jones, M.D., Ph.D., Yago Nieto, M.D., Ph.D., Borje S. Andersson, M.D., Nina Shah, M.D., Betul Oran, M.D., Laurence J.N. Cooper, M.D., Ph.D., Laura Well worth, M.D., Muzaffar H. Qazilbash, M.D., Martin Korbling, M.D., Gabriela Rondon, M.D., Stefan Ciurea, M.D., Doyle Bosque, R.N., Ila Maewal, Pharm.D., Paul J. Simmons, Ph.D., and Elizabeth J. Shpall, M.D.: Cord-Bloodstream Engraftment with Ex Vivo Mesenchymal-Cell Coculture Umbilical-cord blood can be an attractive way to obtain hematopoietic support for individuals who lack a suitable HLA-matched donor.DeBakey Veterans Affairs Medical Baylor and Middle College of Medicine, Houston, studied vital imaging alert notifications in the outpatient setting of one Department of Veterans Affairs service between November 2007 and June 2008. The researchers used tracking software program to determine whether alerts about unusual test outcomes were read within a fortnight, then reviewed medical records and contacted health care practitioners to determine whether timely follow-up actions were taken within four weeks of the alert transmission. Of 123,638 imaging tests performed during the study period, results from 1,196 generated alerts to the ordering clinician.